Trial Profile
A Phase II, Open Label Prospective Single Center Drug Study Evaluating the Safety and Efficacy of (+)-Epicatechin in Subjects With Friedreich's Ataxia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Jan 2022
Price :
$35
*
At a glance
- Drugs Epicatechin (Primary)
- Indications Friedreich's ataxia
- Focus Therapeutic Use
- 04 Feb 2019 Status changed from active, no longer recruiting to completed.
- 27 Oct 2017 Status changed from recruiting to active, no longer recruiting.
- 26 Sep 2016 Status changed from not yet recruiting to recruiting.